###begin article-title 0
###xml 53 76 53 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 53 75 <span type="species:ncbi:727">Haemophilus influenzae</span>
Identification and characterization of a nontypeable Haemophilus influenzae putative toxin-antitoxin locus
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 90 113 90 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 409 410 409 410 <underline xmlns:xlink="http://www.w3.org/1999/xlink">v</underline>
###xml 419 420 419 420 <underline xmlns:xlink="http://www.w3.org/1999/xlink">a</underline>
###xml 441 445 441 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 445 447 445 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 445 447 445 447 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 483 486 483 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 483 486 483 486 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 606 609 606 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 606 609 606 609 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 690 693 690 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 690 693 690 693 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 47 52 <span type="species:ncbi:9606">human</span>
###xml 90 112 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 114 118 <span type="species:ncbi:727">NTHi</span>
###xml 375 379 <span type="species:ncbi:727">NTHi</span>
###xml 396 401 <span type="species:ncbi:9606">human</span>
###xml 974 979 <span type="species:ncbi:9606">human</span>
Certain strains of an obligate parasite of the human upper respiratory tract, nontypeable Haemophilus influenzae (NTHi), can cause invasive diseases such as septicemia and meningitis, as well as chronic mucosal infections such as otitis media. To do this, the organism must invade and survive within both epithelial and endothelial cells. We have identified a facilitator of NTHi survival inside human cells, virulence-associated protein D (vapDHi, encoded by gene HI0450). Both vapDHi and a flanking gene, HI0451, exhibit the genetic and physical characteristics of a toxin/antitoxin (TA) locus, with VapDHi serving as the toxin moiety and HI0451 as the antitoxin. We propose the name VapXHi for the HI0451 antitoxin protein. Originally identified on plasmids, TA loci have been found on the chromosomes of a number of bacterial pathogens, and have been implicated in the control of translation during stressful conditions. Translation arrest would enhance survival within human cells and facilitate persistent or chronic mucosal infections.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 24 27 24 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 170 179 170 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 278 282 278 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 282 285 282 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 282 285 282 285 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 368 382 368 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 458 462 458 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 462 464 462 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 462 464 462 464 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 722 726 722 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 726 729 726 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 726 729 726 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 783 786 783 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 783 786 783 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 997 1014 997 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 1053 1057 1053 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1057 1060 1057 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1057 1060 1057 1060 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1063 1067 1063 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapX</italic>
###xml 1067 1069 1067 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 1067 1069 1067 1069 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 1097 1100 1097 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1097 1100 1097 1100 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1106 1115 1106 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in trans </italic>
###xml 1127 1135 1127 1135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1205 1208 1205 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1205 1208 1205 1208 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 63 68 <span type="species:ncbi:9606">human</span>
###xml 113 118 <span type="species:ncbi:9606">human</span>
###xml 311 315 <span type="species:ncbi:727">NTHi</span>
###xml 368 381 <span type="species:ncbi:727">H. influenzae</span>
###xml 717 721 <span type="species:ncbi:727">NTHi</span>
###xml 997 1013 <span type="species:ncbi:562">Escherichia coli</span>
###xml 1127 1134 <span type="species:ncbi:562">E. coli</span>
Isogenic mutants in vapDHi were attenuated for survival inside human respiratory epithelial cells (NCI-H292) and human brain microvascular endothelial cells (HBMEC), the in vitro models of mucosal infection and the blood-brain barrier, respectively. Transcomplementation with a vapDHi allele restored wild-type NTHi survival within both cell lines. A PCR survey of 59 H. influenzae strains isolated from various anatomical sites determined the presence of a vapDHiallele in 100% of strains. Two isoforms of the gene were identified in this population; one that was 91 residues in length, and another that was truncated to 45 amino acids due to an in-frame deletion. The truncated allele failed to transcomplement the NTHi vapDHi survival defect in HBMEC. Subunits of full-length VapDHi homodimerized, but subunits of the truncated protein did not. However, truncated protein subunits did interact with full-length subunits, and this interaction resulted in a dominant-negative phenotype. Although Escherichia coli does not contain a homologue of either vapDHi or vapXHi, overexpression of the VapDHi toxin in trans resulted in E. coli cell growth arrest. This arrest could be rescued by providing the VapXHi antitoxin on a compatible plasmid.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 21 24 21 24 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapX</italic>
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 32 35 32 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 52 66 52 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 52 65 <span type="species:ncbi:727">H. influenzae</span>
###xml 101 105 <span type="species:ncbi:727">NTHi</span>
###xml 122 127 <span type="species:ncbi:9606">human</span>
We conclude that vapDHi and vapXHi may constitute a H. influenzae TA locus that functions to enhance NTHi survival within human epithelial and endothelial cells.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 11 34 11 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 131 145 131 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 367 368 367 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 369 370 369 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 373 387 373 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 497 498 497 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 553 567 553 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 620 621 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 659 667 659 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 678 692 678 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 763 764 763 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 11 33 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 131 144 <span type="species:ncbi:727">H. influenzae</span>
###xml 197 202 <span type="species:ncbi:9606">human</span>
###xml 357 365 <span type="species:ncbi:9606">patients</span>
###xml 373 386 <span type="species:ncbi:727">H. influenzae</span>
###xml 435 443 <span type="species:ncbi:9606">patients</span>
###xml 553 566 <span type="species:ncbi:727">H. influenzae</span>
###xml 678 691 <span type="species:ncbi:727">H. influenzae</span>
###xml 709 714 <span type="species:ncbi:9606">human</span>
Culturable Haemophilus influenzae are acquired in the nasopharynx shortly after birth, and are thought to persist throughout life. H. influenzae adheres to and penetrates into and between cultured human respiratory epithelial cells, a mechanism that may contribute to its persistence in chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF) patients [1,2]. H. influenzae can be found in the respiratory tracts of these patients even after they have undergone antibiotic treatment [3]. As well, COPD sputum cultures can be sterile, while H. influenzae can still be isolated from the subepithelial matrix [4]. Finally, we have found in a recent in vivo study that H. influenzae can persist in a human bronchiolar xenograft for at least three weeks [5]. This suggests that the organism can survive and persist in protected biological compartment(s).
###end p 9
###begin p 10
###xml 15 29 15 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 357 371 357 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 557 558 557 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 15 28 <span type="species:ncbi:727">H. influenzae</span>
###xml 217 225 <span type="species:ncbi:9606">children</span>
###xml 357 370 <span type="species:ncbi:727">H. influenzae</span>
The ability of H. influenzae to survive antibiotic treatment and reappear when growth is favorable may be responsible for the reseeding of the middle ear observed in chronic otitis media. Often, middle ear fluid from children presenting with otitis media with effusion are sterile when cultured, but PCR analysis of the fluid has determined the presence of H. influenzae [6]. Further, RT-PCR studies of this sterile fluid have shown the presence of bacterial mRNA, confirming that the bacteria are alive and persisting in a viable but nonreplicative state [7].
###end p 10
###begin p 11
###xml 29 38 29 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 586 587 580 581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 46 50 <span type="species:ncbi:727">NTHi</span>
###xml 143 148 <span type="species:ncbi:9606">human</span>
Persistence was investigated in vitro using a NTHi strain that was susceptible to beta-lactam antibiotics. This strain was allowed to invade a human respiratory epithelial cell monolayer for 24 hours, which was subsequently treated with a 4 hour incubation in 10 x MIC concentrations of the beta-lactam antibiotics ampicillin, imipenem, cefuroxim, amoxycillin/clavulanic acid, or cephalothin. The antibiotics killed all the extracellular bacteria, but none of the intra- or paracellular bacteria, suggesting that the organism was not replicating inside or between the epithelial cells [8]. Non-replicating bacteria are not susceptible to the cidal action of beta-lactam and aminoglycoside antibiotics.
###end p 11
###begin p 12
###xml 128 149 128 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dichelobacter nodosus</italic>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al</italic>
###xml 202 203 202 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 417 421 417 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapA</italic>
###xml 422 423 422 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 429 430 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">v</italic>
###xml 429 430 429 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>v</italic></bold>
###xml 439 440 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">a</italic>
###xml 439 440 439 440 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>a</italic></bold>
###xml 450 451 450 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 450 451 450 451 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>p</italic></bold>
###xml 577 598 577 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neisseria gonorrhoeae</italic>
###xml 600 646 600 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Helicobacter pylori, Reimerella anatipestifer </italic>
###xml 650 686 650 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actinobacillus actinomycetemcomitans</italic>
###xml 706 720 706 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 783 787 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapA</italic>
###xml 789 794 789 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapBC</italic>
###xml 800 805 800 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD </italic>
###xml 832 837 832 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapBC</italic>
###xml 884 888 884 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vap </italic>
###xml 897 911 897 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 932 942 932 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D. nodosus</italic>
###xml 952 956 952 956 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapA</italic>
###xml 956 959 956 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 956 959 956 959 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1086 1090 1086 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1090 1093 1090 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1090 1093 1090 1093 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1191 1195 1191 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapX</italic>
###xml 1195 1197 1195 1197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 1195 1197 1195 1197 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 1306 1310 1306 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vap </italic>
###xml 1372 1376 1372 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1376 1379 1376 1379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1376 1379 1376 1379 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1512 1514 1512 1514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1521 1524 1521 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1521 1524 1521 1524 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1564 1578 1564 1578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dichelobacter </italic>
###xml 128 149 <span type="species:ncbi:870">Dichelobacter nodosus</span>
###xml 577 598 <span type="species:ncbi:485">Neisseria gonorrhoeae</span>
###xml 600 619 <span type="species:ncbi:210">Helicobacter pylori</span>
###xml 650 686 <span type="species:ncbi:714">Actinobacillus actinomycetemcomitans</span>
###xml 706 719 <span type="species:ncbi:727">H. influenzae</span>
###xml 897 910 <span type="species:ncbi:727">H. influenzae</span>
###xml 932 942 <span type="species:ncbi:870">D. nodosus</span>
###xml 1357 1361 <span type="species:ncbi:727">NTHi</span>
During a study aimed at identifying genes associated with virulence in pathogenic strains of the Gram-negative, strict anaerobe Dichelobacter nodosus, the causative agent of ovine footrot, Katz et al. [9] reported the discovery of a novel area of the chromosome that hybridized to all virulent strains tested, but to only 23% of the avirulent strains studied. They designated the four genes found on this fragment as vapA-D, for virulence-associated proteins. Homologues of these genes appear on the chromosomes and plasmids of a number of pathogenic microorganisms, including Neisseria gonorrhoeae, Helicobacter pylori, Reimerella anatipestifer and Actinobacillus actinomycetemcomitans. The chromosome of H. influenzae strain Rd KW20 (hereinafter referred to as strain Rd) contains vapA, vapBC, and vapD homologues, with one pair, vapBC, in duplicate. The genome organization of the vap genes in H. influenzae differs from that of D. nodosus, in that vapAHi (HI1250) is preceded by a conserved hypothetical protein, HI1251, and both genes are likely transcribed as an operon. As well, vapDHi is flanked by a gene encoding another conserved hypothetical protein, HI0451 (which we have named vapXHi), again in an apparent operon configuration (8 nucleotides separate HI0450 and HI0451). To determine if the vap homologues played a role in the persistence of NTHi, we chose vapDHi (HI0450) for further study, since this protein was found in a proteomic survey to be expressed in the soluble fraction of strain Rd [10]. VapDHi is 40% identical and 67% similar to the Dichelobacter VapD and belongs to the Cluster of Orthologous Groups (COG) 3309 and Pfam 04605, termed the "N-terminal conserved domain of VapD".
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 16 19 16 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 53 58 <span type="species:ncbi:9606">human</span>
Mutation of vapDHi results in attenuated survival in human endothelial cells
###end title 14
###begin p 15
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 16 19 16 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 56 65 56 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 334 336 334 336 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 386 388 386 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 406 410 406 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 410 413 410 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 410 413 410 413 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 511 513 511 513 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t </italic>
###xml 585 589 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 589 592 589 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 589 592 589 592 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 753 755 753 755 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 774 776 774 776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 794 798 794 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 798 801 798 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 798 801 798 801 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 99 104 <span type="species:ncbi:9606">human</span>
###xml 619 624 <span type="species:ncbi:9606">human</span>
When the Rd vapDHi mutant strain was used to invade the in vitro model of the blood-brain barrier, human brain microvascular endothelial cells (HBMEC) in 12-well plates, the amount of gentamicin-resistant bacteria recovered from the monolayer after three hours declined to approximately 60% of wild type levels, an average of 2.2 x 103 CFU/ml for the wild-type strain Rd versus 1.3 x 103 CFU/ml for the Rd vapDHi mutant (n = 3 (number of independent assays performed in at least duplicate); P < 0.05, Student's t test). No significant difference was observed between the wild type and vapDHi mutant in adherence to the human cell monolayers: the average number of cell-associated bacteria (both adherent and invaded) recovered for strain Rd was 1.5 x 105 CFU/ml and 1.8 x 105 CFU/ml for the Rd vapDHi mutant (n = 3; P > 0.05).
###end p 15
###begin p 16
###xml 72 76 72 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 76 79 76 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 76 79 76 79 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 383 384 383 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 483 485 483 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 535 537 535 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 558 562 558 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 562 565 562 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 562 565 562 565 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 829 833 827 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 833 836 831 834 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 833 836 831 834 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 939 943 937 941 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 943 946 941 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 943 946 941 944 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1072 1074 1070 1072 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 1096 1098 1094 1096 <sup xmlns:xlink="http://www.w3.org/1999/xlink">7 </sup>
###xml 1115 1119 1113 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1119 1122 1117 1120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1119 1122 1117 1120 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1290 1292 1288 1290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1358 1362 1356 1360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1362 1365 1360 1363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1362 1365 1360 1363 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 303 310 <span type="species:ncbi:9606">patient</span>
To determine if the phenotype of attenuated survival observed in the Rd vapDHi mutant was a general phenomenon and not restricted to strain Rd, another isogenic pair was constructed and analyzed using a different strain, R3001. R3001 is a bronchoalveolar lavage isolate from a pediatric cystic fibrosis patient, and is considered invasive since it came from a normally sterile site [5]. The average number of gentamicin-resistant bacteria recovered from HBMEC monolayers was 1.2 x 105 CFU/ml for the parent strain R3001 versus 7.1 x 104 CFU/ml for the R3001 vapDHi mutant (n = 3; P < 0.05). Although the absolute numbers of bacteria recovered were higher with strain R3001 than with Rd (as is often observed with invasive isolates), the attenuation of survival inside the HBMEC monolayer of </= 60% observed in the strain with a vapDHi mutation was maintained. There was no significant difference between the wild-type R3001 and the R3001 vapDHi mutant in adherence to the monolayer: the average numbers of cell-associated bacteria recovered for strain R3001 were 1.7 x 107 CFU/ml versus 1.3 x 107 CFU/ml for R3001 vapDHi (n = 4; P > 0.05). Unlike Rd, strain R3001 carries the high molecular weight (HMW) adhesins, which may account for its more efficient adherence to the HBMEC monolayer [11]. No significant difference in the growth rates of either of the vapDHi mutants versus their cognate parent strains were observed, whether grown in bacteriological media (sBHI broth) or on HBMEC or NCI-H292 monolayers (data not shown).
###end p 16
###begin title 17
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 16 19 16 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 67 72 <span type="species:ncbi:9606">human</span>
Mutation of vapDHi results in diminished long-term survival inside human respiratory epithelial cells
###end title 17
###begin p 18
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 24 27 24 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 64 78 64 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 370 372 370 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 394 396 394 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">4 </sup>
###xml 414 418 414 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 418 421 418 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 418 421 418 421 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 498 502 498 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 502 505 502 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 502 505 502 505 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 64 77 <span type="species:ncbi:727">H. influenzae</span>
###xml 96 101 <span type="species:ncbi:9606">human</span>
To determine if the vapDHi mutation would affect the ability of H. influenzae to survive inside human respiratory epithelial cells over a longer period of time, 18-hour invasion assays were performed using NCI-H292 cells. The number of gentamicin-resistant bacteria recovered from the NCI-H292 monolayer after 18 hours for the parent strain Rd was an average of 6.4 x 104 CFU/ml versus 3.2 x 104 CFU/ml for the Rd vapDHi mutant (n = 3; P < 0.05). This represents a 50% reduction in survival of the vapDHi mutant within epithelial cells as compared to the parent strain, more attenuation than was seen for the three hour assays.
###end p 18
###begin title 19
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 31 33 31 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 31 33 31 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
Transcomplementation of Rd vapDHi
###end title 19
###begin p 20
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 8 11 8 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 160 163 160 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 160 163 160 163 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 303 317 303 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 318 320 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 466 470 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 470 473 470 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 470 473 470 473 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 479 488 479 488 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in trans </italic>
###xml 522 526 522 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 526 529 526 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 526 529 526 529 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 713 715 713 715 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 771 773 771 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 829 833 829 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 833 836 833 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 833 836 833 836 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 843 851 843 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in trans</italic>
###xml 856 860 856 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 860 863 860 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 860 863 860 863 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1136 1140 1136 1140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1140 1143 1140 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1140 1143 1140 1143 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 303 316 <span type="species:ncbi:727">H. influenzae</span>
The vapDHi locus from strain R3001 was cloned into the mobilizable broad host range plasmid pDD515, creating pDD564, and conjugally transferred into the Rd vapDHi mutant (Table 1). The plasmid pDD515 is a derivative of the IncQ plasmid RSF1010 and has an approximate copy number of 12 per chromosome in H. influenzae [12]. The survival inside HBMEC of strain Rd (pDD515) was within 5% of strain Rd without the vector in identical assays (data not shown). Carrying a vapDHi locus in trans restored wild-type survival of Rd vapDHi (pDD564) within HBMEC monolayers. The amount of gentamicin-resistant bacteria recovered from the endothelial cell monolayer after a three hour invasion assay was an average of 8.0 x 102 CFU/ml for Rd (pDD515), the vector control, and 7.6 x 102 CFU/ml for the mutant strain that carried the wild-type vapDHi allele in trans, Rd vapDHi (pDD564) (n = 3; P > 0.05), indicating that there was no significant difference in the survival inside HBMEC monolayers of the wild type strain versus the transcomplemented strain. These data confirm that the phenotype of attenuated survival was due to the interruption in vapDHi and not to polar effects.
###end p 20
###begin p 21
###xml 10 14 10 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 14 17 14 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 70 74 70 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 74 77 74 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 74 77 74 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 218 222 218 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 222 225 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 222 225 222 225 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 535 537 535 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
The R3001 vapDHi mutant mirrored the survival defect seen with the Rd vapDHi mutant, at approximately 60% of wild-type R3001 levels. However, attempts to conjugate the mobilizable broad host range plasmid carrying the vapDHi locus, pDD564, into strain R3001 for transcomplementation studies failed repeatedly. This clinical isolate likely has a plasmid or an origin of replication of the same incompatibility group incorporated into its chromosome and therefore will not maintain the broad host range plasmid for transcomplementation [13].
###end p 21
###begin title 22
###xml 43 48 <span type="species:ncbi:9606">human</span>
Reverse-transcriptase PCR of bacteria from human cell monolayers
###end title 22
###begin p 23
###xml 20 24 20 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 24 27 24 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 293 297 293 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 297 299 297 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 297 299 297 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 673 677 673 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 677 679 677 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 677 679 677 679 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 71 76 <span type="species:ncbi:9606">human</span>
###xml 741 746 <span type="species:ncbi:9606">human</span>
To determine if the vapDHi locus was transcribed during contact with a human cell monolayer, total RNA was isolated from the wild-type strain Rd recovered after 18 hours on HBMEC or NCI-H292 monolayers and was used as the template for RT-PCR. Figure 1 shows the 153 bp band amplified with the vapDHi-specific primers, with a molecular weight marker in lane A. The template for lane B is Rd RNA from HBMEC endothelial cell monolayers, lane C is its cognate negative control, with no reverse transcriptase added to the RNA prior to PCR amplification. Lane D shows the results using Rd RNA from NCI-H292 epithelial cell monolayers; lane E is its cognate negative control. The vapDHilocus is transcribed when strain Rd is in contact with either human epithelial or endothelial cell monolayers.
###end p 23
###begin title 24
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 18 20 18 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 18 20 18 20 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
PCR survey of vapDHi
###end title 24
###begin p 25
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 46 49 46 49 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 175 176 175 176 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 183 186 183 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vap</italic>
###xml 290 294 290 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 294 297 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 294 297 294 297 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 79 83 <span type="species:ncbi:727">NTHi</span>
In order to estimate the carriage rate of vapDHi among the highly heterologous NTHi strains, a PCR survey of 59 commensal and disease-associated strains was undertaken (Table 2). The vapHI primer set was used. In Rd, these primers amplify a 769 bp PCR product that includes the full-length vapDHi gene.
###end p 25
###begin p 26
###xml 121 135 121 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 274 277 274 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vap</italic>
###xml 545 549 545 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 549 551 549 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 549 551 549 551 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 62 66 <span type="species:ncbi:727">NTHi</span>
###xml 121 134 <span type="species:ncbi:727">H. influenzae</span>
###xml 313 317 <span type="species:ncbi:727">NTHi</span>
Purified chromosomal DNA preparations from 53 randomly-chosen NTHi strains and one each of the six capsular serotypes of H. influenzae (types a through f) from the American Type Culture Collection (ATCC) reference strains described in Table 2 were subjected to PCR with the vapHI forward and reverse primers. The NTHi strains included nasopharyngeal, blood, CSF, middle ear, tracheal aspirate, and sputum isolates. A PCR product was amplified in 100% of the strains. All of the ATCC encapsulated reference strains and Rd displayed a full-length vapDHiallele. Ninety-three percent of the nasopharyngeal strains carried a full-length allele, as did 71% of the blood and CSF isolates, and 50% of the middle ear, tracheal aspirate, and sputum isolates. Overall, only ten strains of the 59 included in the study displayed a truncated gene.
###end p 26
###begin title 27
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 32 35 32 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
Sequencing of the truncated vapDHi allele
###end title 27
###begin p 28
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 27 30 27 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 27 30 27 30 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 118 121 118 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 118 121 118 121 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 438 439 438 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 722 726 722 726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 726 729 726 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 726 729 726 729 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 770 774 770 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 774 777 774 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 774 777 774 777 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 920 934 920 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N. gonorrhoeae</italic>
###xml 936 946 936 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori </italic>
###xml 950 974 950 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A. actinomycetemcomitans</italic>
###xml 995 1005 995 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D. nodosus</italic>
###xml 1073 1087 1073 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 920 934 <span type="species:ncbi:485">N. gonorrhoeae</span>
###xml 936 945 <span type="species:ncbi:210">H. pylori</span>
###xml 950 974 <span type="species:ncbi:714">A. actinomycetemcomitans</span>
###xml 995 1005 <span type="species:ncbi:870">D. nodosus</span>
###xml 1073 1086 <span type="species:ncbi:727">H. influenzae</span>
To study the truncated vapDHi in more detail, five out of the ten alleles that represented the smaller isoform of vapDHi from the PCR survey were sequenced on both strands. It was found that, in all cases, the gene had undergone a deletion event that had left the protein in frame, but missing 46 amino acids from the interior of the protein, resulting in a 45 amino acid protein rather than the full-length 91 amino acid protein (Figure 2). This corresponds to the loss of Rd genome coordinates 473123 to 473263. In addition, all of the smaller alleles had an aspartate residue inserted at position #7 as compared to Rd, which has a leucine at that position. The significance of this is unclear, as the full-length R3001 vapDHi allele, which did transcomplement the Rd vapDHi mutant, also has an aspartic acid inserted at the same position, resulting in a 91 amino acid protein. Interestingly, the VapD homologues from N. gonorrhoeae, H. pylori and A. actinomycetemcomitans, as well as VapD in D. nodosus, all have an aspartate at that position. Rd appears to be the only H. influenzae strain studied which lacks that particular residue.
###end p 28
###begin title 29
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 16 19 16 19 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
Full-length VapDHi homodimerizes
###end title 29
###begin p 30
###xml 9 16 9 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 189 191 189 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 402 405 402 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 402 405 402 405 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 583 586 583 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 583 586 583 586 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 859 864 859 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 9 16 <span type="species:ncbi:562">E. coli</span>
Using an E. coli-based protein-protein interaction system that is dependent upon the DNA-binding domain (DBD) of LexA, homodimerization of identical protein subunits can be quantitated [14,15]. In this system, protein-protein interactions result in a LexA dimer that is active as a repressor, and consequently, the beta-galactosidase activity of the reporter strain (SU101) diminishes. Full-length VapDHi from strain R3001 was ligated to the DBD of LexA in plasmid pDD559 and the clones were analyzed on MacConkey agar with lactose. If there was no homodimerization of the LexA::VapDHi fusion protein, the colonies appeared red on MacConkey agar, as the native level of beta-galactosidase expression in the reporter strain was not inhibited. If the subunits interacted, the colonies appeared pale on MacConkey, as the engineered LexA operator controlling the lacZ reporter gene had been repressed by a homodimer of the LexA fusion protein. This repression was quantitated by beta-galactosidase activity assays. Each measurement is the mean of at least three experiments performed in triplicate.
###end p 30
###begin p 31
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 22 25 22 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 246 249 244 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 246 249 244 247 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 355 358 351 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 355 358 351 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 375 382 371 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 529 534 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
It was found that VapDHi interacted strongly with itself. The beta-galactosidase activity of the reporter strain SU101 carrying the vector control (pSR658) was an average of 975 (+/- 29) Miller units, and the activity of SU101 with the LexA::VapDHi fusion (pDD559) was an average of 16 (+/- 1) Miller units, indicating strong interaction. Full-length VapDHi forms homodimers in vivo. This protein may also form higher-order multimers, since this would result in a number of dimeric forms being available to act as a repressor of lacZ transcription in the reporter strain.
###end p 31
###begin title 32
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 14 17 14 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 75 77 75 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 75 77 75 77 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
Truncated VapDHi does not homodimerize, but interacts with full-length VapDHi
###end title 32
###begin p 33
###xml 94 97 94 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 94 97 94 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 285 288 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 285 288 283 286 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
Homodimerization assays with the small allele revealed that the subunits of the truncated VapDHi did not interact efficiently. The vector control for the homodimerization assays SU101 (pSR658) yielded 1490 (+/- 31) Miller units, and SU101 carrying the LexA fusion to the truncated VapDHi protein from strain R2866 (pDD577) displayed 1357 (+/- 54) Miller units of beta-galactosidase activity, showing little repression in this system.
###end p 33
###begin p 34
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 24 27 24 27 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 307 312 307 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 428 431 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 428 431 428 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 499 502 499 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 499 502 499 502 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 774 778 774 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
###xml 1049 1052 1047 1050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1049 1052 1047 1050 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1151 1154 1149 1152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1151 1154 1149 1152 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1336 1339 1332 1335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1336 1339 1332 1335 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
Since the wild-type VapDHi subunits homodimerized strongly but the truncated subunits did not, the truncated subunit and the full-length subunit were examined for interaction in heterodimerization assays. In the reporter strain SU202, a LexA operator with a mutated half-site was engineered upstream of the lacZ gene. This strain was then transformed with two compatible plasmids, one that carried a fusion of the truncated VapDHi with a wild-type LexA DBD, and one that carried the full-length VapDHi fusion to a mutated LexA DBD that only recognized the mutated LexA operator half-site in SU202 [15]. If a heterodimer of a truncated subunit and a full-length subunit was formed, a functional LexA repressor could recognize the hybrid operator and repress transcription of lacZ. It was determined that the truncated and full-length subunits could interact with each other. The vector control for the heterodimerization assays (SU202 with pSR658 and pSR659) yielded 1855 +/- 196 Miller units, and SU202 carrying the LexA fusion to the truncated VapDHi protein from strain R2866, pDD577, coupled with the mutated LexA DBD fusion to the full-length VapDHi protein from strain R3001, pDD561, resulted in 792 +/- 19 Miller units of beta-galactosidase activity, showing that the truncated subunit did heterodimerize with the full-length VapDHi subunit.
###end p 34
###begin title 35
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 14 17 14 17 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
Truncated VapDHi does not transcomplement the mutant and has a dominant-negative effect in the wild-type strain
###end title 35
###begin p 36
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 41 44 41 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 272 275 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 272 275 272 275 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 459 461 459 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 520 522 520 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 536 540 536 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 540 542 540 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 540 542 540 542 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 676 680 676 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 680 683 680 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 680 683 680 683 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 727 731 727 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 731 734 731 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 731 734 731 734 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
To investigate whether the truncated VapDHi protein could transcomplement a mutation in the full-length gene, the truncated locus from strain R2866 was cloned into the mobilizable broad host range vector pDD515, creating pDD594, and conjugally transferred into the Rd vapDHi mutant strain. Three-hour survival assays using HBMEC monolayers were performed, and the number of gentamicin-resistant bacteria recovered from the monolayer was an average of 5.6 x 102 CFU/ml for Rd (pDD515), the vector control, versus 1.9 x 102 CFU/ml for Rd vapDHi(pDD594) (n = 3; P < 0.005). Survival in HBMEC by the mutant strain did not increase to wild-type levels, as was the case with the Rd vapDHi mutant transcomplemented with a full-length vapDHi allele on pDD564.
###end p 36
###begin p 37
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 38 41 38 41 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 288 291 288 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 288 291 288 291 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 652 654 652 654 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 676 678 676 678 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 725 734 725 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in trans </italic>
###xml 760 764 760 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 764 767 764 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 764 767 764 767 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 414 419 <span type="species:ncbi:9606">human</span>
Since subunits of the full-length VapDHi and the truncated protein interacted, the plasmid pDD594 carrying the truncated allele was conjugally transferred into wild-type strain Rd to determine whether expression of the small protein would interfere with the function of the wild-type VapDHi protein. The strain was used in three-hour assays of HBMEC monolayers, and it was found that Rd (pDD594) was attenuated in human cell survival as compared to Rd (pDD515), the wild-type strain carrying the vector without an insert. The average number of gentamicin-resistant bacteria recovered from the monolayer for Rd (pDD515), the vector control, was 5.7 x 102 CFU/ml versus 1.8 x 102 CFU/ml for Rd (pDD594) (n = 3; P < 0.005). The in trans expression of a truncated vapDHi allele in the wild-type strain Rd resulted in a dominant-negative effect on survival within HBMEC monolayers.
###end p 37
###begin title 38
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 18 21 18 21 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 24 41 24 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 24 40 <span type="species:ncbi:562">Escherichia coli</span>
Expression of vapDHi in Escherichia coli DH5alpha results in cell growth arrest
###end title 38
###begin p 39
###xml 32 35 32 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 32 35 32 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 71 74 71 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 71 74 71 74 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 154 162 154 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 174 182 174 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 249 252 249 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 249 252 249 252 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 351 354 351 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 351 354 351 354 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 393 397 393 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trc </italic>
###xml 393 397 393 397 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>trc </italic></sub>
###xml 851 855 833 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 855 858 837 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 855 858 837 840 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 871 878 853 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 907 909 889 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 907 909 889 891 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 1026 1029 1004 1007 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1026 1029 1004 1007 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1040 1044 1018 1022 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapX</italic>
###xml 1044 1047 1022 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1044 1047 1022 1025 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1061 1065 1039 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacI</italic>
###xml 1065 1067 1043 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">q </italic>
###xml 1065 1067 1043 1045 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>q </italic></sup>
###xml 1271 1275 1245 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1275 1278 1249 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1275 1278 1249 1252 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1321 1325 1295 1299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapX</italic>
###xml 1325 1328 1299 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1325 1328 1299 1302 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1393 1397 1367 1371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trc </italic>
###xml 1393 1397 1367 1371 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>trc </italic></sub>
###xml 1705 1709 1673 1677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapX</italic>
###xml 1709 1712 1677 1680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1709 1712 1677 1680 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1731 1735 1699 1703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1735 1738 1703 1706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1735 1738 1703 1706 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1807 1811 1775 1779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1811 1814 1779 1782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1811 1814 1779 1782 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1830 1834 1798 1802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapX</italic>
###xml 1834 1837 1802 1805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1834 1837 1802 1805 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 154 161 <span type="species:ncbi:562">E. coli</span>
###xml 174 181 <span type="species:ncbi:562">E. coli</span>
###xml 871 878 <span type="species:ncbi:562">E. coli</span>
To test the hypothesis that VapDHi constituted the toxin, and that VapXHi encoded the antitoxin portion of a TA locus, both proteins were expressed in an E. coli background. E. coli does not contain a homologue of either protein. Initially, the vapDHi gene, HI0450, was cloned into the pTrcHisA vector (Invitrogen, Carlsbad, CA). This resulted in vapDHi being under the control of the strong Ptrc promoter, which is repressed for the most part until induced by IPTG. This plasmid was designated pDD560. Both the vector control, DH5alpha (pTrcHisA), and DH5alpha (pDD560) were grown to mid-log phase in LB broth with 100 mug/ml ampicillin and aliquots were spread on LB agar plates with 100 mug/ml ampicillin and 0.1 mM IPTG. Strain DH5alpha (pTrcHisA) grew on the plates, but DH5alpha (pDD560) did not, indicating that induction and overexpression of vapDHi was toxic to E. coli. The putative antitoxin VapXHi, was then cloned into the pTrcHisA vector. No growth disruption occurred in DH5alpha with the overexpression of VapXHi alone. The vapXHi gene plus the lacIq gene were then subcloned into the broad host range mobilizable plasmid, pDD515, resulting in pDD672. This strategy allowed the DH5alpha test strain to carry two compatible plasmids, one which encoded the vapDHi gene (pDD560) and the other expressing the vapXHi antitoxin gene (pDD672). Both genes were under the control of a Ptrc promoter and were therefore both repressed until induced by IPTG. When both genes were induced with 0.1 mM IPTG on LB agar plates that contained 100 mug/ml ampicillin and 10 mug/ml chloramphenicol in strain DH5alpha (pDD560, pDD672), growth was restored. This indicated that the concurrent expression of the vapXHi antitoxin with the vapDHi toxin ameliorated the cell growth arrest observed with expression of vapDHi alone, and that vapXHi was necessary for this rescue.
###end p 39
###begin title 40
Discussion
###end title 40
###begin p 41
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 20 23 20 23 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 152 165 152 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae</italic>
###xml 200 203 200 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 200 203 200 203 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 456 468 454 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus </italic>
###xml 577 579 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 580 582 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 585 599 583 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 677 680 675 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 677 680 675 678 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 749 753 747 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vap </italic>
###xml 760 764 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapA</italic>
###xml 764 766 762 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 764 766 762 764 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 768 772 766 770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapB</italic>
###xml 772 774 770 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 772 774 770 772 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 780 784 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapC</italic>
###xml 784 786 782 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 784 786 782 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 819 835 817 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus vap </italic>
###xml 1090 1113 1088 1111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Leptospira interrogans </italic>
###xml 1114 1116 1112 1114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1161 1173 1159 1171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus </italic>
###xml 1206 1210 1204 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vap </italic>
###xml 152 165 <span type="species:ncbi:727">H. influenzae</span>
###xml 300 305 <span type="species:ncbi:9606">human</span>
###xml 585 598 <span type="species:ncbi:727">H. influenzae</span>
###xml 615 620 <span type="species:ncbi:9606">human</span>
###xml 1090 1112 <span type="species:ncbi:173">Leptospira interrogans</span>
Mutation of the vapDHi allele in strains Rd and R3001 resulted in attenuation of survival within both HBMEC and NCI-H292 monolayers, suggesting that in H. influenzae, the presence of a functional VapDHi facilitates persistence within epithelial and endothelial cells. Mutants invaded and survived in human cells at </= 60% of wild-type levels. Although relatively modest, this level of attenuation has been observed during the mutational analysis of other Haemophilus virulence factors, such as opacity-associated protein A as well as the high molecular weight (HMW) proteins [11,16]. H. influenzae survival within human cells is multifactorial, and our data indicate that VapDHi contributes to this process. However, strain Rd contains three other vap genes (vapAHi, vapBHi, and vapCHi), and it is possible that these Haemophilus vap genes act synergistically, such that multiple mutations may result in a more attenuated survival phenotype. Indeed, a recent study has determined that a chromosomally-located homologue of the VapBC locus acts as a toxin-antitoxin module in the spirochete Leptospira interrogans [17]. It would be interesting to characterize a Haemophilus strain with mutations in all the vap genes.
###end p 41
###begin p 42
###xml 15 19 15 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 19 22 19 22 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 242 246 242 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 246 249 246 249 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 599 603 599 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 603 606 603 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 603 606 603 606 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 717 721 717 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 721 724 721 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 721 724 721 724 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 789 796 789 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 845 849 845 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 849 852 849 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 849 852 849 852 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 943 946 943 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 943 946 943 946 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1040 1042 1040 1042 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 382 387 <span type="species:ncbi:9606">human</span>
###xml 1130 1135 <span type="species:ncbi:9606">human</span>
Neither of the vapDHi mutants displayed differences in adherence to the monolayers compared to the parent strain, so the defect occurred after binding and affected the organism's ability to persist inside or between cells. Interestingly, the vapDHi mutants were not attenuated in growth rate when compared to the parent strains, either in bacteriological media or on the surface of human cell monolayers. The observed survival attenuation of the mutants could be transcomplemented with a full-length allele from a clinical isolate, R3001, demonstrating that the phenotype was due to the mutation in vapDHi and not polar effects. A truncated allele from another clinical isolate, R2866, did not transcomplement the Rd vapDHi strain, indicating that the truncated protein was not functional in vivo. RT-PCR analysis confirmed that the full-length vapDHi locus in Rd was transcribed during contact with both epithelial and endothelial cells. VapDHi has also been identified in the soluble fraction of strain Rd grown in bacteriological media [10]. It remains to be seen if the transcription of this locus increases upon contact with human cells.
###end p 42
###begin p 43
###xml 177 181 177 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 181 184 181 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 181 184 181 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 261 264 261 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 261 264 261 264 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 317 318 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 935 937 935 937 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 1010 1014 1010 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1014 1017 1014 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1014 1017 1014 1017 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 116 120 <span type="species:ncbi:727">NTHi</span>
###xml 757 761 <span type="species:ncbi:727">NTHi</span>
###xml 875 880 <span type="species:ncbi:9606">human</span>
Results of a PCR survey on 59 randomly-chosen strains showed that nearly all of the genetically highly heterologous NTHi commensal isolates surveyed (93%) carried a full-length vapDHi allele on their chromosomes, suggesting that maintenance of a functional vapDHi gene was beneficial to survival in this niche (Table 2). Of the invasive strains isolated from the blood or cerebrospinal fluid, 71% retained a full-length allele. Fifty percent of the isolates from sputum, tracheal aspirates, and the middle ear carried the full-length allele. Finally, all the encapsulated strains tested contained a full-length allele. It must be noted, however, that this analysis was not an exhaustive study, since a limited number of strains were included. Many clinical NTHi strains have previously been shown to express various virulence factors that enhance adherence and invasion into human cells which are not found in the sequenced Rd strain [11,18-20]. The strains identified in this PCR study that lack a functional vapDHi allele probably compensate for its loss with genes that are not found in Rd, and these "extra genes" may well include other TA loci.
###end p 43
###begin p 44
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 41 44 41 44 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 158 161 158 161 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 361 368 361 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 656 664 656 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 876 880 876 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 880 883 880 883 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 880 883 880 883 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
The calculated molecular mass of the VapDHi protein in Rd is approximately 10 kilodaltons, and small bacterial proteins often form multimers. Full-length VapDHi subunits exhibited strong homodimerization in a LexA-based protein-protein interaction system, and this may indicate that the subunits form higher-order multimers such as homotrimers or homotetramers in vivo. However, the protein encoded by the truncated allele did not homodimerize in the same system, further evidence of its loss of function. Interestingly, the truncated subunit did interact with full-length subunits in heterodimerization assays. Further evidence of this heterodimerization in vivo was that the expression of the truncated subunit in the wild-type strain resulted in a dominant-negative effect on survival within HBMEC monolayers, the levels of which mimicked the attenuation observed with the vapDHi mutation. This was likely due to truncated subunits forming hybrid complexes with full-length subunits and interfering with their structure and/or function, resulting in the observed dominant-negative phenotype.
###end p 44
###begin p 45
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 433 438 433 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">relBE</italic>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 527 533 527 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">relBE </italic>
###xml 590 595 590 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">higA </italic>
###xml 596 597 596 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink">h</italic>
###xml 601 602 601 602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">i</italic>
###xml 615 616 615 616 <italic xmlns:xlink="http://www.w3.org/1999/xlink">g</italic>
###xml 663 669 663 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">higBA </italic>
###xml 713 717 713 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">higB</italic>
###xml 760 764 760 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">higA</italic>
###xml 786 789 786 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 786 789 786 789 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
The activities of only a few toxins encoded by TA loci have been elucidated thus far. Two specific targets of plasmid-encoded toxins have been identified: CcdB of the F plasmid and ParE of plasmid RK2 inhibit DNA gyrase, and Kid of plasmid R1 was previously thought to interact with DnaB helicase, but has recently been shown to cleave cellular mRNA [21-23]. The target and function of a toxin from a chromosomally-encoded TA locus (relBE) was determined to be cleavage of mRNA in the ribosomal A site [24]. Strain Rd contains relBE homologues (HI0710 and HI0711) as well as a homologue of higA (host inhibition of growth antidote protein) from plasmid Rts1. The higBA TA locus is unusual in that the toxin gene (higB) exists upstream of the antidote protein (higA). Interestingly, VapAHi of strain Rd is 29% identical and 53% similar to HigA.
###end p 45
###begin p 46
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 56 59 56 59 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 67 70 67 70 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 139 142 139 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 139 142 139 142 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 150 164 150 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 192 206 192 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 252 256 252 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 256 259 256 259 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 285 289 285 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapX</italic>
###xml 289 292 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 289 292 289 292 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 470 497 470 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. pylori, N. meningitidis </italic>
###xml 501 519 501 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus somnus</italic>
###xml 568 572 568 572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 572 574 572 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 572 574 572 574 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 606 610 606 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 610 612 610 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 610 612 610 612 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 613 617 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapX</italic>
###xml 617 620 617 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 617 620 617 620 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 150 163 <span type="species:ncbi:727">H. influenzae</span>
###xml 192 205 <span type="species:ncbi:727">H. influenzae</span>
###xml 470 479 <span type="species:ncbi:210">H. pylori</span>
###xml 481 496 <span type="species:ncbi:487">N. meningitidis</span>
###xml 501 519 <span type="species:ncbi:731">Haemophilus somnus</span>
While the data acquired in this study suggests that VapDHi and VapXHi form a toxin-antitoxin pair, it is unusual to find homologues of VapXHi only in H. influenzae and the gonococcal plasmid. H. influenzae strains R2846 and R2866 both have a truncated vapDHi toxin gene, and possess a vapXHi which is 100% identical to that gene in strain Rd. Their respective genomes can be searched at . Interestingly, there are complete genome sequences available for two isolates of H. pylori, N. meningitidis and Haemophilus somnus, but only one strain of each has a homologue of vapDHi. Thus, several features of the vapDHi/vapXHi gene pair are unusual for a toxin-antitoxin locus.
###end p 46
###begin title 47
Conclusions
###end title 47
###begin p 48
###xml 256 257 256 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 258 259 258 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 260 261 260 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 262 264 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 268 270 268 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 353 366 353 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae</italic>
###xml 440 443 440 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 440 443 440 443 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 15 19 <span type="species:ncbi:727">NTHi</span>
###xml 231 235 <span type="species:ncbi:727">NTHi</span>
###xml 243 248 <span type="species:ncbi:9606">human</span>
###xml 353 366 <span type="species:ncbi:727">H. influenzae</span>
###xml 496 500 <span type="species:ncbi:727">NTHi</span>
###xml 516 521 <span type="species:ncbi:9606">human</span>
Persistence of NTHi is important in the progression of disease caused by this organism. Many investigators have previously reported the discovery of a number of virulence factors associated with adherence, invasion and survival of NTHi inside human cells [1,3,4,16,18,25]. Here we report a locus that is also involved in the pathogenesis of nontypeable H. influenzae. Further studies are required to fully characterize the mechanism of VapDHi function and to define its role in the modulation of NTHi persistence in human cells.
###end p 48
###begin title 49
Methods
###end title 49
###begin title 50
Bacterial strains, media and reagents
###end title 50
###begin p 51
###xml 4 18 4 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 51 52 51 52 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 54 68 54 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 468 470 461 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 658 675 650 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 890 892 878 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 893 895 881 883 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 4 17 <span type="species:ncbi:727">H. influenzae</span>
###xml 54 67 <span type="species:ncbi:727">H. influenzae</span>
###xml 658 674 <span type="species:ncbi:562">Escherichia coli</span>
###xml 725 729 <span type="species:ncbi:727">NTHi</span>
All H. influenzae strains used are listed in Table 2. H. influenzae was grown on chocolate agar (36 g Difco GC medium, 10 g hemoglobin, 10 ml Difco Supplement B (Becton Dickinson, Sparks, MD), 5,000 Units bacitracin per liter) or supplemented BHI (sBHI) broth or agar (37 g brain heart infusion media +/- 15 g Bacto agar per liter (Remel, Lenexa, KS) with 10 mug/ml beta-NAD, 10 mug/ml heme-histidine, and 5 Units/ml bacitracin). Strains containing the TSTE cassette [26] were grown on media with 15 mug/ml ribostamycin sulfate (CalBioChem, San Diego, CA). Bacteria were diluted for plating with PBS-G (phosphate-buffered saline (pH 7.0) with 0.1% gelatin). Escherichia coli strains used were DH5alpha, to clone fragments of NTHi DNA; DD12, as the host strain in conjugations; and SU101 or SU202 as the reporter strains for the homodimerization and heterodimerization assays, respectively [14,15]. T4 bacteriophage was obtained from the American Type Culture Collection (ATCC #11303). Antibiotics and other chemicals were from Sigma-Aldrich (St. Louis, MO). Restriction enzymes, deoxyribonucleotides, T4 DNA polymerase, and T4 DNA ligase were from Promega (Madison, WI). Enzymes and other reagents for PCR were from Eppendorf Scientific (Westbury, NY) and Bioline (Canton, MA). Enzymes and reagents for reverse transcriptase PCR (MasterAmp RT-PCR Kit) were from Epicentre Technologies (Madison, WI). Oligonucleotide primers were synthesized by Integrated DNA Technologies (Coralville, IA). DNA sequencing was performed by the University of Missouri DNA Core Facility (Columbia, MO), Davis Sequencing, LLC (Davis, CA), and the DNA Core Facility at Seattle Biomedical Research Institute (Seattle, WA). Plasmids were isolated using the Wizard SV Plus Plasmid Miniprep kit, PCR products and restriction digests were purified using the Wizard PCR Prep kit, and total bacterial RNA was isolated using the SV Total RNA Isolation System (Promega, Madison, WI).
###end p 51
###begin title 52
Plasmids and conjugations
###end title 52
###begin p 53
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 47 50 47 50 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 140 143 140 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vap</italic>
###xml 161 167 161 167 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TCTAGA</underline>
###xml 191 194 191 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vap</italic>
###xml 212 218 212 218 <underline xmlns:xlink="http://www.w3.org/1999/xlink">TCTAGA</underline>
###xml 264 269 264 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XbaI </italic>
###xml 392 397 392 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XbaI </italic>
###xml 419 421 419 421 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 460 465 460 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NheI </italic>
###xml 586 600 586 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 601 603 601 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 637 638 637 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 696 700 696 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 700 702 700 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 700 702 700 702 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 767 771 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 771 774 771 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 771 774 771 774 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 841 846 841 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NheI </italic>
###xml 962 966 962 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 966 969 966 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 966 969 966 969 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1042 1044 1042 1044 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1155 1159 1155 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1159 1162 1159 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1159 1162 1159 1162 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1208 1218 1208 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aph (3')II</italic>
###xml 1247 1253 1247 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BamHI </italic>
###xml 1274 1276 1274 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1362 1368 1362 1368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BsaBI </italic>
###xml 1376 1380 1376 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1380 1382 1380 1382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 1380 1382 1380 1382 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 1507 1511 1507 1511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1511 1514 1511 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1511 1514 1511 1514 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 1546 1550 1546 1550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1550 1552 1550 1552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 1550 1552 1550 1552 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 1630 1632 1630 1632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 1755 1759 1755 1759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 1759 1762 1759 1762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 1759 1762 1759 1762 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 586 599 <span type="species:ncbi:727">H. influenzae</span>
###xml 1489 1493 <span type="species:ncbi:727">NTHi</span>
###xml 1528 1532 <span type="species:ncbi:727">NTHi</span>
For transcomplementation, the 276 bp R3001 vapDHi allele, along with 269 bp upstream and 227 bp downstream, was PCR-amplified using primers vapHI forward 5'-TATGTCTAGACAGTCGCTTCATAAGC-3' and vapHI reverse 5'-CCATTCTAGATTTGAGGTTAAATATGG-3'. Both primers included a XbaI site (underlined) and amplified Rd genome coordinates 472803 to 473572. The product was sequenced and cloned both into the XbaI site of pBluescript SK+ (creating plasmid pDD562) and into the NheI site of pDD515, a mobilizable broad-host range vector that could be conjugally transferred into and stably maintained in H. influenzae [12], creating plasmid pDD564 (Table 1). Plasmid pDD564 was used for transcomplementation of Rd vapDHi. The same primers were used to PCR amplify the 135 bp truncated vapDHi allele from strain R2866, the product of which was cloned into the NheI site of pDD515, creating pDD594. The insert was sequenced, then the plasmid was conjugally transferred into both Rd vapDHi and wild-type Rd. Conjugations were carried out as previously described [12]. For allelic exchange, the plasmid pDD563 was constructed, which consisted of pDD562 with an interruption of vapDHi by an aminoglycoside phosphotransferase gene (aph (3')II). Specifically, the 2184 bp BamHI fragment from pTSTE [26], which had been rendered blunt-ended with mung bean nuclease, was inserted into the BsaBI site of vapDHi. For the homodimerization assays, the plasmids pDD559 and pDD577 were derived from pSR658 and carried the NTHi strain R3001 vapDHi allele or the NTHi strain R2866 vapDHiallele fused in-frame to the wild-type LexA DNA-binding domain, respectively [27]. For the heterodimerization assays, the plasmid pDD561 derived from pSR659 was constructed, which consisted of the R3001 vapDHi allele fused in-frame to the mutated LexA DNA-binding domain.
###end p 53
###begin title 54
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 16 18 16 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 16 18 16 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
Mutation of vapDHi
###end title 54
###begin p 55
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 8 11 8 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 189 194 189 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XmnI </italic>
###xml 370 374 369 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 374 377 373 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 374 377 373 376 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 466 470 465 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 470 473 469 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 470 473 469 472 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 617 628 616 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aph (3')II </italic>
###xml 658 662 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 662 664 661 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 662 664 661 663 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 745 749 744 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 749 752 748 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 749 752 748 751 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
The vapDHi genes in Rd and strain R3001 were disrupted by allelic exchange. Briefly, strains Rd and R3001 were made competent using the M-IV media technique [28] and pDD563 linearized with XmnI was used to transform each strain. Transformants were selected on chocolate agar supplemented with 15 mug/ml ribostamycin sulfate (CalBioChem, San Diego, CA). The insertion in vapDHi was confirmed by Southern blotting using a digoxygenin-labeled denatured PCR fragment of vapDHi as the probe. The orientation of the aminoglycoside phosphotransferase cassette was determined by PCR using a primer that originated inside the aph (3')II gene and another that flanked vapDHi. The resistance gene was found to be transcribed in the opposite orientation of vapDHi in both strains.
###end p 55
###begin title 56
Cell culture
###end title 56
###begin p 57
###xml 81 83 81 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 752 754 752 754 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 370 374 <span type="species:ncbi:9913">calf</span>
Human brain microvascular endothelial cells (HBMECs) were a gift from K. S. Kim [29]. Cells were passaged in collagen-1 coated T-25 flasks and monolayers for invasion assays were grown in 12-well collagen-1 coated BioCoat plates (Becton Dickinson, Bedford, MA). HBMEC media contained 760 ml RPMI 1640 with 25 mM HEPES and 2 mM L-glutamine, 100 ml heat-inactivated fetal calf serum, 10 ml each of 200 mM L-glutamine, 100x MEM non-essential amino acid solution, 100x MEM vitamin solution, 100 mM MEM sodium pyruvate solution (Gibco, Grand Island, NY), and 100 ml heat-inactivated NuSerum V (Becton Dickinson, Bedford, MA) per liter. Media was changed every two days and cells were passaged every 3-5 days. Monolayers were seeded at a density of ~2.0 x 105 cells per well and used 48 to 72 hours after seeding.
###end p 57
###begin p 58
###xml 708 710 708 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5 </sup>
###xml 9 14 <span type="species:ncbi:9606">human</span>
###xml 555 559 <span type="species:ncbi:9913">calf</span>
NCI-H292 human respiratory epithelial cells (ATCC catalogue # CRL-1848) were passaged in collagen-1 coated T-25 flasks and monolayers for invasion assays were grown to confluency in 12-well collagen-1 coated BioCoat plates (Becton Dickinson, Bedford, MA). NCI-H292 media consisted of 870 ml RPMI 1640 medium with 25 mM HEPES and 2 mM L-glutamine, 10 ml of 100 mM MEM sodium pyruvate solution, 10 ml of 7.5% w/v sodium bicarbonate solution (Gibco, Grand Island, NY), 10 ml of 450 mg/ml filter-sterilized glucose solution, and 100 ml heat-inactivated fetal calf serum per liter. As above, media was changed every two days and cells were passaged every 3-5 days. Monolayers were seeded at a density of ~2.5 x 105 cells per well and used 72 to 96 hours after seeding.
###end p 58
###begin title 59
Invasion and survival assays
###end title 59
###begin p 60
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 173 175 173 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6 </sup>
###xml 182 196 182 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 323 325 321 323 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 182 195 <span type="species:ncbi:727">H. influenzae</span>
Gentamicin-resistance invasion and survival assays were performed on HBMEC and NCI-H292 monolayers as previously described [5]. Briefly, the inoculum used was 1.0 - 5.0 x 106 CFU of H. influenzae in a volume of 1 ml per well of a 12-well plate (an MOI of </= 10:1). After a 3 or 18 hour incubation in an atmosphere of 5% CO2 at 37degreesC, each monolayer was extensively washed with Dulbecco's PBS and 1.5 ml of media containing 100 mug/ml gentamicin was added to each well. Following a subsequent one hour incubation in the antibiotic, the wells were again washed extensively, harvested with 1% saponin, diluted in PBS-G and plated on chocolate or sBHI agar for viable intracellular CFU/ml. To quantitate total cell-associated bacteria (both intracellular and adherent), wells were also harvested and plated after the first wash and prior to gentamicin addition.
###end p 60
###begin title 61
Methods for statistical analysis
###end title 61
###begin p 62
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P</italic>
Statistical analyses were performed using the statistical analysis functions of Microsoft Excel (Microsoft Office 1997). For most comparisons of data, the Student's t-test was used and P-values of <0.05 were considered to indicate statistically significant differences.
###end p 62
###begin title 63
Reverse transcriptase PCR (RT-PCR)
###end title 63
###begin p 64
###xml 893 897 893 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 897 900 897 900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 897 900 897 900 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
Total RNA was isolated using the SV Total RNA isolation system (Promega, Madison, WI) from the wild type strain Rd recovered from the media of 18-hour invasions of either HBMEC (endothelial) or NCI-H292 (epithelial) monolayers. Standard procedures were used, with the modification that two separate DNAseI incubations were performed instead of the single one recommended with the kit. RT-PCR using the MasterAmp RT-PCR kit was then performed as per the manufacturer's instructions (Epicentre Technologies, Madison, WI). Negative controls of no reverse transcriptase added to the RNA followed by traditional PCR using Biolase DNA polymerase (Bioline, Madison, WI) were used to ensure that both RNA preparations were free of contaminating DNA. The primers for RT-PCR, 450 RT for (5'-CAGGCTTATACAGACATTGG-3') and 450 RT rev (5'-TCGTACCGACTGAGAAATCC-3') amplified a 153 bp internal portion of the vapDHi cDNA.
###end p 64
###begin title 65
Protein-protein interaction assays
###end title 65
###begin p 66
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 8 11 8 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 286 288 286 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 517 521 517 521 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ</italic>
###xml 581 585 581 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 585 588 585 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 585 588 585 588 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 748 752 748 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 752 754 752 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 752 754 752 754 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 778 782 778 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 782 784 782 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi</italic>
###xml 782 784 782 784 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi</italic></sub>
###xml 885 887 885 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 900 905 900 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 1339 1344 1339 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lacZ </italic>
###xml 1454 1456 1454 1456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
The vapDHi alleles from strains R3001 (full-length) and R2866 (truncated) were amplified by PCR and fused in-frame to the LexA DNA-binding domain (DBD) in pSR658, resulting in pDD559 and pDD577, respectively, and used to transform the reporter strain SU101 for homodimerization assays [27]. Briefly, strain SU101 carries a lacZ gene controlled by a wild-type LexA operator site [14]. If a homodimer of two LexA DBD fusions was formed, the complex could bind to the LexA operator region and shut down transcription of lacZ, resulting in diminished levels of beta-galactosidase. The vapDHi allele from strain R3001 was also fused in-frame to the mutated LexA DNA-binding domain in pSR659, creating pDD561. The compatible plasmids pDD561 (full length vapDHi) and pDD577 (truncated vapDHi) were both used to transform the reporter strain SU202 for heterodimerization assays. Strain SU202 [14] also has a lacZ gene controlled by a LexA operator, but this operator site is engineered such that only a mutated LexA DBD subunit (coded on pSR659) can bind to one half-site, while a wild-type LexA DBD subunit (coded on pSR658) can bind to the other half-site. Consequently, only a heterodimer composed of one mutated LexA DBD fusion subunit and one wild-type LexA DBD fusion subunit could bind to this engineered site and decrease transcription of lacZ in SU202. Three independent beta-galactosidase assays were carried out in triplicate as previously described [27].
###end p 66
###begin title 67
Author's contributions
###end title 67
###begin p 68
DAD conceived of the study, carried out the protein-protein interaction and molecular genetics work, and drafted the manuscript. JJ carried out the intracellular survival experiments. ALS supported the study and participated in its design and coordination. All authors read and approved the final manuscript.
###end p 68
###begin title 69
Acknowledgements
###end title 69
###begin p 70
###xml 48 53 <span type="species:ncbi:9606">human</span>
The authors thank K.S. Kim for his kind gift of human brain microvascular endothelial cells and D. Nguyen for his technical assistance. This work was supported by NIH grants AI 07276 and AI 44002.
###end p 70
###begin article-title 71
###xml 15 38 15 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 15 37 <span type="species:ncbi:727">Haemophilus influenzae</span>
Paracytosis of Haemophilus influenzae through cell layers of NCI-H292 lung epithelial cells
###end article-title 71
###begin article-title 72
###xml 57 80 57 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 21 26 <span type="species:ncbi:9606">human</span>
###xml 57 79 <span type="species:ncbi:727">Haemophilus influenzae</span>
Infection of primary human bronchial epithelial cells by Haemophilus influenzae : macropinocytosis as a mechanism of airway epithelial cell entry
###end article-title 72
###begin article-title 73
###xml 9 32 9 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 9 31 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
Multiple Haemophilus influenzae strains and strain variants coexist in the respiratory tract of patients with cystic fibrosis
###end article-title 73
###begin article-title 74
Virulence factors in the colonization and persistence of bacteria in the airways
###end article-title 74
###begin article-title 75
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 0 30 <span type="species:ncbi:71421">Haemophilus influenzae Rd KW20</span>
Haemophilus influenzae Rd KW20 has virulence properties
###end article-title 75
###begin article-title 76
###xml 18 41 18 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 18 40 <span type="species:ncbi:727">Haemophilus influenzae</span>
High incidence of Haemophilus influenzae in nasopharyngeal secretions and middle ear effusions as detected by PCR
###end article-title 76
###begin article-title 77
Evidence of bacterial metabolic activity in culture-negative otitis media with effusion
###end article-title 77
###begin article-title 78
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 0 22 <span type="species:ncbi:727">Haemophilus influenzae</span>
Haemophilus influenzae localized in epithelial cell layers is shielded from antibiotics and antibody-mediated bactericidal activity
###end article-title 78
###begin article-title 79
###xml 76 99 76 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dichelobacter nododsus </italic>
Molecular characterization of a genomic region associated with virulence in Dichelobacter nododsus
###end article-title 79
###begin article-title 80
###xml 39 61 39 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae</italic>
###xml 39 61 <span type="species:ncbi:727">Haemophilus influenzae</span>
Two-dimensional map of the proteome of Haemophilus influenzae
###end article-title 80
###begin article-title 81
###xml 50 73 50 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 50 72 <span type="species:ncbi:727">Haemophilus influenzae</span>
High-molecular-weight surface-exposed proteins of Haemophilus influenzae mediate binding to macrophages
###end article-title 81
###begin article-title 82
###xml 29 52 29 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 29 51 <span type="species:ncbi:727">Haemophilus influenzae</span>
Design and construction of a Haemophilus influenzae conjugal expression system
###end article-title 82
###begin article-title 83
###xml 89 101 89 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus </italic>
Site-specific recombination with the chromosomal tRNA(Leu) gene by the large conjugative Haemophilus resistance plasmid
###end article-title 83
###begin article-title 84
###xml 91 107 91 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 91 107 <span type="species:ncbi:562">Escherichia coli</span>
A new LexA-based genetic system for monitoring and analyzing protein heterodimerization in Escherichia coli
###end article-title 84
###begin article-title 85
###xml 86 103 86 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 86 102 <span type="species:ncbi:562">Escherichia coli</span>
Evidence for multimerization of Neu proteins involved in polysialic acid synthesis in Escherichia coli K1 using improved LexA-based vectors
###end article-title 85
###begin article-title 86
###xml 59 82 59 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 59 81 <span type="species:ncbi:727">Haemophilus influenzae</span>
Opacity-associated protein A contributes to the binding of Haemophilus influenzae to Chang epithelial cells
###end article-title 86
###begin article-title 87
###xml 70 93 70 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Leptospira interrogans </italic>
###xml 70 92 <span type="species:ncbi:173">Leptospira interrogans</span>
Characterization of a novel toxin-antitoxin module, VapBC, encoded by Leptospira interrogans chromosome
###end article-title 87
###begin article-title 88
###xml 50 73 50 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 50 72 <span type="species:ncbi:727">Haemophilus influenzae</span>
High-molecular-weight surface-exposed proteins of Haemophilus influenzae mediate binding to macrophages
###end article-title 88
###begin article-title 89
###xml 47 70 47 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae.</italic>
###xml 47 69 <span type="species:ncbi:727">Haemophilus influenzae</span>
The pathogenesis of disease due to nontypeable Haemophilus influenzae.
###end article-title 89
###begin article-title 90
###xml 51 74 51 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 51 73 <span type="species:ncbi:727">Haemophilus influenzae</span>
Partial analysis of the genomes of two nontypeable Haemophilus influenzae otitis media isolates
###end article-title 90
###begin article-title 91
Toxin-antitoxin modules may regulate synthesis of macromolecules during nutritional stress
###end article-title 91
###begin article-title 92
Mechanisms of plasmid stable maintenance with special focus on plasmid addiction systems
###end article-title 92
###begin article-title 93
Interference of mRNA function by sequence-specific endoribonuclease PemK
###end article-title 93
###begin article-title 94
The bacterial toxin RelE displays codon-specific cleavage of mRNAs in the ribosomal A site
###end article-title 94
###begin article-title 95
###xml 12 35 12 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 12 34 <span type="species:ncbi:727">Haemophilus influenzae</span>
###xml 93 98 <span type="species:ncbi:9606">human</span>
Nontypeable Haemophilus influenzae : a review of clinical aspects, surface antigens, and the human immune response to infection
###end article-title 95
###begin article-title 96
###xml 47 70 47 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 47 69 <span type="species:ncbi:727">Haemophilus influenzae</span>
A novel approach to insertional mutagenesis of Haemophilus influenzae
###end article-title 96
###begin article-title 97
###xml 68 75 68 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Use of a LexA-based system to identify protein-protein interactions in vivo
###end article-title 97
###begin article-title 98
###xml 67 90 67 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Haemophilus influenzae </italic>
###xml 67 89 <span type="species:ncbi:727">Haemophilus influenzae</span>
Defined non-growth media for stage II development of competence in Haemophilus influenzae
###end article-title 98
###begin article-title 99
###xml 51 56 <span type="species:ncbi:9606">human</span>
Bacterial invasion and transcytosis in transfected human brain microvascular endothelial cells
###end article-title 99
###begin title 100
Figures and Tables
###end title 100
###begin p 101
###xml 0 32 0 32 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Agarose gel of RT-PCR products. </bold>
###xml 159 164 <span type="species:ncbi:9606">human</span>
###xml 196 201 <span type="species:ncbi:9606">human</span>
Agarose gel of RT-PCR products. Reverse-transcriptase PCR (RT-PCR) of total RNA isolated from wild-type strain Rd after 18 hours of contact with either HBMEC (human endothelial cell) or NCI-H292 (human epithelial cell) monolayers. Lane A: Molecular weight marker (Promega 1 Kb ladder); lane B: RNA from Rd on HBMEC monolayers; lane C: Negative control for lane B (no reverse transcriptase added prior to PCR); lane D: RNA from Rd on NCI-H292 monolayers; lane E: Negative control for lane D (no reverse transcriptase added prior to PCR).
###end p 101
###begin p 102
###xml 45 48 45 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 45 48 45 48 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Multiple sequence alignment of truncated VapD<sub><italic>Hi </italic></sub>proteins. </bold>
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 84 87 84 87 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
Multiple sequence alignment of truncated VapDHi proteins. Wild type full-length VapDHi protein sequence from strain Rd is included for comparison. R296: middle ear isolate; R3122: blood isolate; R2751: sputum isolate; R2866: blood isolate; R3270: nasopharynx isolate.
###end p 102
###begin p 103
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 13 20 <span type="species:ncbi:562">E. coli</span>
Plasmids and E. coli strains used in this study.
###end p 103
###begin p 104
###xml 0 14 0 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">H. influenzae </italic>
###xml 0 13 <span type="species:ncbi:727">H. influenzae</span>
H. influenzae strains used in this study.
###end p 104
###begin p 105
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 178 181 178 181 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
###xml 286 290 281 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vapD</italic>
###xml 290 293 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hi </italic>
###xml 290 293 285 288 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Hi </italic></sub>
*: Asterisk denotes derivative strains, i.e. R3460 is strain R652 carrying the vector pDD515. The marked strains are not included in computing the incidence of the wild-type vapDHi allele versus the truncated allele. Independent strains are not marked with an asterisk. dagger: Type of vapDHi allele: WT = wild type (91 amino acids); TV = truncated version (45 amino acids). double dagger: Site from which strains were isolated.
###end p 105

